Bellerophon Therapeutics Inc buy melinda
Start price
12.02.17
/
50%
€9.76
Target price
14.02.17
€10.82
Performance (%)
28.93%
End price
14.02.17
€12.58
Summary
This prediction ended on 14.02.17 with a price of €12.58. The BUY prediction by melinda finished with a performance of 28.93%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Bellerophon Therapeutics Inc | - | - | - | - |
| iShares Core DAX® | 1,72 % | 3,37 % | 5,89 % | 52,38 % |
| iShares Nasdaq 100 | -4,56 % | -4,24 % | 21,39 % | 72,45 % |
| iShares Nikkei 225® | -7,12 % | -11,87 % | 42,36 % | 57,58 % |
| iShares S&P 500 | -0,89 % | 1,69 % | 19,49 % | 62,15 % |
Comments by melinda for this prediction
In the thread Bellerophon Therapeutics Inc diskutieren
Lungenfibrose
a +
(Zielkurs erreicht)
Stopped prediction by melinda for Bellerophon Therapeutics Inc
Bellerophon Therapeutics Inc
Start price
Target price
Perf. (%)
€8.66
25.05.19
25.05.19
€16.24
04.11.21
04.11.21
-96.60%
04.01.21
04.01.21
Bellerophon Therapeutics Inc
Start price
Target price
Perf. (%)
€36.53
16.12.17
16.12.17
€40.59
18.06.18
18.06.18
-9.26%
18.06.18
18.06.18
Bellerophon Therapeutics Inc
Start price
Target price
Perf. (%)
€40.50
16.12.17
16.12.17
€45.00
18.06.18
18.06.18
-9.26%
18.06.18
18.06.18
Bellerophon Therapeutics Inc
Start price
Target price
Perf. (%)
€25.91
08.03.17
08.03.17
€33.83
08.09.17
08.09.17
-39.41%
08.09.17
08.09.17
Bellerophon Therapeutics Inc
Start price
Target price
Perf. (%)
€15.83
21.02.17
21.02.17
€27.06
27.02.17
27.02.17
12.82%
27.02.17
27.02.17


